Your browser doesn't support javascript.
loading
SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study.
Shields, Adrian M; Faustini, Sian E; Hill, Harriet J; Al-Taei, Saly; Tanner, Chloe; Ashford, Fiona; Workman, Sarita; Moreira, Fernando; Verma, Nisha; Wagg, Hollie; Heritage, Gail; Campton, Naomi; Stamataki, Zania; Klenerman, Paul; Thaventhiran, James E D; Goddard, Sarah; Johnston, Sarah; Huissoon, Aarnoud; Bethune, Claire; Elcombe, Suzanne; Lowe, David M; Patel, Smita Y; Savic, Sinisa; Burns, Siobhan O; Richter, Alex G.
Afiliación
  • Shields AM; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. a.m.shields@bham.ac.uk.
  • Faustini SE; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK. a.m.shields@bham.ac.uk.
  • Hill HJ; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Al-Taei S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Tanner C; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Ashford F; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Workman S; Clinical Immunology Service, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Moreira F; Department of Immunology, Royal Free London NHS Foundation Trust, London, UK.
  • Verma N; Department of Immunology, Royal Free London NHS Foundation Trust, London, UK.
  • Wagg H; Department of Immunology, Royal Free London NHS Foundation Trust, London, UK.
  • Heritage G; Institute of Translational Medicine, University of Birmingham, Birmingham, UK.
  • Campton N; Institute of Translational Medicine, University of Birmingham, Birmingham, UK.
  • Stamataki Z; Institute of Translational Medicine, University of Birmingham, Birmingham, UK.
  • Klenerman P; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Thaventhiran JED; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Goddard S; Medical Research Council Toxicology Unit, University of Cambridge, Gleeson Building, Tennis Court Road, Cambridge, CB2 1QW, UK.
  • Johnston S; Department of Clinical Immunology, University Hospitals North Midlands, Stoke-on-Trent, UK.
  • Huissoon A; Department of Clinical Immunology, North Bristol NHS Trust, Bristol, UK.
  • Bethune C; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Elcombe S; Department of Allergy and Clinical Immunology, University Hospitals Plymouth NHS Trust, Plymouth, UK.
  • Lowe DM; Department of Allergy and Clinical Immunology, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.
  • Patel SY; Department of Immunology, Royal Free London NHS Foundation Trust, London, UK.
  • Savic S; Institute of Immunity and Transplantation, University College London, London, UK.
  • Burns SO; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Richter AG; NIHR BRC Oxford Biomedical Centre, University of Oxford, Oxford, UK.
J Clin Immunol ; 42(5): 923-934, 2022 07.
Article en En | MEDLINE | ID: mdl-35420363
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases Asunto principal: Vacunas Virales / Enfermedades de Inmunodeficiencia Primaria / COVID-19 Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: J Clin Immunol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 4_covid_19 / 4_pneumonia / 6_other_respiratory_diseases Asunto principal: Vacunas Virales / Enfermedades de Inmunodeficiencia Primaria / COVID-19 Tipo de estudio: Diagnostic_studies Límite: Humans Idioma: En Revista: J Clin Immunol Año: 2022 Tipo del documento: Article País de afiliación: Reino Unido